EcoDrugPlus

Ensembl ID : ENSEEEG00000010908
Gene Symbol: -
1 Cross references
306 Possible Orthologues:

Ensembl ID : ENSEEEG00000010906
Gene Symbol: -
Cross references: -
306 Possible Orthologues:

Ensembl ID : ENSEEEG00000015989
Gene Symbol: -
1 Cross references
213 Possible Orthologues:

Ensembl ID : ENSEEEG00000010856
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSEEEG00000004716
Gene Symbol: -
Cross references: -
615 Possible Orthologues:

Ensembl ID : ENSEEEG00000000517
Gene Symbol: -
Cross references: -
137 Possible Orthologues:

Ensembl ID : ENSEEEG00000004717
Gene Symbol: -
Cross references: -
628 Possible Orthologues:

Ensembl ID : ENSEEEG00000005281
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSEEEG00000010023
Gene Symbol: -
Cross references: -
298 Possible Orthologues:

Ensembl ID : ENSEEEG00000012000
Gene Symbol: -
Cross references: -
628 Possible Orthologues:

Ensembl ID : ENSEEEG00000012002
Gene Symbol: -
Cross references: -
628 Possible Orthologues:

Ensembl ID : ENSEEEG00000020509
Gene Symbol: -
1 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).